|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Tyra Biosciences, Inc. (TYRA) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
41,270,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Tyra Biosciences is an oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Co. is focused on developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor, or FGFR family. Co.'s lead product candidate, TYRA-300, is designed to selectively inhibit Fibroblast Growth Factor Receptor3, with an initial focus on patients with bladder cancer. In addition, Co. has pipeline development programs targeting FGFR2-related cancers, FGFR3-related achondroplasia, REarranged during Transfection kinase, and FGFR4-related cancers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
21,298 |
221,691 |
456,290 |
785,314 |
| Total Sell Value |
$427,399 |
$3,766,874 |
$7,701,881 |
$12,216,507 |
| Total People Sold |
1 |
2 |
2 |
3 |
| Total Sell Transactions |
10 |
15 |
38 |
53 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Tada Hiroomi |
Chief Medical OfficerOfficer |
• – – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
77,922 |
|
- |
|
| Kaplan Gilla Phd |
Director |
– • – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
28,231 |
|
- |
|
| Swanson Ronald V. |
Chief Scientific OfficerOffice |
• – – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
270,129 |
|
- |
|
| Chen Isan |
Director |
– • – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
131,339 |
|
- |
|
| Hudkins Robert L. |
Chief Technology OfficerOffice |
• – – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
270,128 |
|
- |
|
| Van Den Boom Esther |
Chief Financial OfficerOfficer |
• – – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
118,645 |
|
- |
|
| Patel Piyush R. |
Chief Development OfficerOffic |
• – – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
135,064 |
|
- |
|
| Harris Todd |
Chief Executive OfficerOfficer |
• • – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,662,336 |
|
- |
|
| Janney Daniel |
10% Owner |
– – • |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
112,929 |
|
- |
|
| Bensen Daniel |
Chief Operating OfficerOfficer |
• – – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
519,480 |
|
- |
|
135 Records found
|
|
Page 6 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
